Real-World Effectiveness of Chemotherapy in Elderly Patients With Metastatic Bladder Cancer in the United States-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-World Effectiveness of Chemotherapy in Elderly Patients With Metastatic Bladder Cancer in the United States

Published:2018-04-26 Issue:2 Volume:4 Page:227-238
ISSN:2352-3727
Container-title:Bladder Cancer
language:
Short-container-title:BLC

Author:

Galsky Matthew D.¹,Pal Sumanta Kumar²,Lin Shih-Wen³,Ogale Sarika³,Zivkovic Marko⁴,Simpson Joseph³,Derleth Christina³,Schiff Christina³,Sonpavde Guru⁵

Affiliation:

1. Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

2. Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA

3. Genentech, Inc, South San Francisco, CA, USA

4. Genesis Research, Hoboken, NJ, USA

5. University of Alabama Comprehensive Cancer Center, Birmingham, AL, USA

Publisher

IOS Press

Subject

Urology,Oncology

Reference28 articles.

1. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study;Loehrer;J Clin Oncol,1992

2. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J Clin Oncol,2005

3. Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy;Bellmunt;Ann Oncol,2013

4. Current approaches to the management of bladder cancer in older patients;Stensland;Am Soc Clin Oncol Educ Book,2014

5. Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer;Galsky;Urol Oncol,2014

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with receipt of systemic anticancer treatment for locally advanced or metastatic urothelial carcinoma in England: a population-based study;Urologic Oncology: Seminars and Original Investigations;2024-07

2. Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis;Cancers;2024-06-05

3. Treatment Patterns and Survival Outcomes Before and After Access to Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma: A Single-Center Retrospective Study From 2004 to 2021;Clinical Genitourinary Cancer;2024-06

4. Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US;JAMA Network Open;2024-05-02

5. Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab;Journal of Clinical Oncology;2024-04-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3